Bowen Hanes & Co’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $8.65M | Hold |
17,595
| – | – | 0.21% | 63 |
|
|
2026
Q1 | $8.65M | Sell |
17,595
-83,910
| -83% | -$45.5M | 0.21% | 63 |
|
|
2025
Q4 | $58.8M | Sell |
101,505
-2,545
| -2% | -$1.44M | 1.48% | 32 |
|
|
2025
Q3 | $50.5M | Buy |
104,050
+23,220
| +29% | +$10.8M | 1.26% | 37 |
|
|
2025
Q2 | $32.8M | Sell |
80,830
-48,837
| -38% | -$20.4M | 0.83% | 46 |
|
|
2025
Q1 | $64.5M | Buy |
129,667
+1,601
| +1% | +$867K | 1.79% | 23 |
|
|
2024
Q4 | $66.6M | Buy |
128,066
+10,250
| +9% | +$5.64M | 1.79% | 22 |
|
|
2024
Q3 | $72.9M | Sell |
117,816
-805
| -0.7% | -$477K | 1.91% | 18 |
|
|
2024
Q2 | $65.6M | Sell |
118,621
-525
| -0.4% | -$301K | 1.82% | 20 |
|
|
2024
Q1 | $69.2M | Buy |
119,146
+297
| +0.2% | +$167K | 1.98% | 19 |
|
|
2023
Q4 | $63.1M | Buy |
118,849
+297
| +0.3% | +$144K | 1.9% | 24 |
|
|
2023
Q3 | $60M | Buy |
118,552
+2,521
| +2% | +$1.34M | 2.02% | 13 |
|
|
2023
Q2 | $60.5M | Buy |
116,031
+354
| +0.3% | +$191K | 1.94% | 18 |
|
|
2023
Q1 | $66.7M | Sell |
115,677
-1,647
| -1% | -$928K | 2.29% | 7 |
|
|
2022
Q4 | $64.6M | Buy |
117,324
+2,296
| +2% | +$1.22M | 2.29% | 7 |
|
|
2022
Q3 | $58.3M | Sell |
115,028
-5,907
| -5% | -$3.31M | 2.26% | 7 |
|
|
2022
Q2 | $65.7M | Sell |
120,935
-985
| -0.8% | -$542K | 2.38% | 4 |
|
|
2022
Q1 | $72M | Sell |
121,920
-13,885
| -10% | -$7.98M | 2.15% | 8 |
|
|
2021
Q4 | $90.6M | Sell |
135,805
-11,016
| -8% | -$6.88M | 2.56% | 3 |
|
|
2021
Q3 | $83.9M | Sell |
146,821
-2,724
| -2% | -$1.5M | 2.58% | 2 |
|
|
2021
Q2 | $75.4M | Sell |
149,545
-1,615
| -1% | -$762K | 2.29% | 6 |
|
|
2021
Q1 | $69M | Sell |
151,160
-999
| -0.7% | -$477K | 2.2% | 9 |
|
|
2020
Q4 | $70.9M | Sell |
152,159
-9,597
| -6% | -$4.5M | 2.36% | 5 |
|
|
2020
Q3 | $71.4M | Sell |
161,756
-2,263
| -1% | -$935K | 2.58% | 3 |
|
|
2020
Q2 | $59.4M | Sell |
164,019
-3,323
| -2% | -$1.11M | 2.4% | 7 |
|
|
2020
Q1 | $47.5M | Sell |
167,342
-660
| -0.4% | -$208K | 2.32% | 6 |
|
|
2019
Q4 | $54.6M | Sell |
168,002
-14,975
| -8% | -$4.54M | 2.25% | 6 |
|
|
2019
Q3 | $53.3M | Sell |
182,977
-24,555
| -12% | -$7.03M | 2.27% | 7 |
|
|
2019
Q2 | $60.9M | Buy |
207,532
+295
| +0.1% | +$81.3K | 2.62% | 2 |
|
|
2019
Q1 | $56.7M | Buy |
207,237
+5,369
| +3% | +$1.34M | 2.51% | 2 |
|
|
2018
Q4 | $45.2M | Sell |
201,868
-1,491
| -0.7% | -$350K | 2.27% | 5 |
|
|
2018
Q3 | $49.6M | Sell |
203,359
-773
| -0.4% | -$178K | 2.19% | 7 |
|
|
2018
Q2 | $42.3M | Sell |
204,132
-10,971
| -5% | -$2.33M | 1.98% | 11 |
|
|
2018
Q1 | $44.4M | Sell |
215,103
-1,950
| -0.9% | -$409K | 2.06% | 9 |
|
|
2017
Q4 | $41.2M | Sell |
217,053
-855
| -0.4% | -$164K | 1.84% | 12 |
|
|
2017
Q3 | $41.2M | Buy |
217,908
+5,060
| +2% | +$916K | 1.94% | 9 |
|
|
2017
Q2 | $37.1M | Sell |
212,848
-4,483
| -2% | -$753K | 1.82% | 10 |
|
|
2017
Q1 | $33.4M | Buy |
217,331
+4,672
| +2% | +$714K | 1.68% | 15 |
|
|
2016
Q4 | $30M | Sell |
212,659
-5,780
| -3% | -$852K | 1.61% | 20 |
|
|
2016
Q3 | $34.7M | Sell |
218,439
-4,870
| -2% | -$750K | 1.84% | 9 |
|
|
2016
Q2 | $33M | Sell |
223,309
-6,640
| -3% | -$980K | 1.79% | 15 |
|
|
2016
Q1 | $32.6M | Sell |
229,949
-665
| -0.3% | -$89.1K | 1.8% | 15 |
|
|
2015
Q4 | $32.7M | Sell |
230,614
-2,776
| -1% | -$370K | 1.83% | 9 |
|
|
2015
Q3 | $28.5M | Buy |
233,390
+112,390
| +93% | +$14.6M | 1.64% | 14 |
|
|
2015
Q2 | $15.7M | Buy |
+121,000
| New | +$15.8M | 0.78% | 70 |
|
Other funds holding TMO
Bowen Hanes & Co's TMO Position: Q2 2026 in Review
Bowen Hanes & Co held its Thermo Fisher Scientific (TMO) position steady in Q2 2026 at 17,595 shares worth $8.65M. The position accounts for 0.21% of the portfolio, ranked #63.
Bowen Hanes & Co first reported a position in TMO in Q2 2015 and has held it in 45 quarters since. The position peaked at $90.6M in Q4 2021. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- Bowen Hanes & Co held 17,595 shares of Thermo Fisher Scientific worth $8.65M as of Q2 2026.
- Bowen Hanes & Co left its Thermo Fisher Scientific share count unchanged in Q2 2026.
- Thermo Fisher Scientific made up 0.21% of Bowen Hanes & Co's portfolio in Q2 2026, its #63 holding.
- Bowen Hanes & Co first reported a position in Thermo Fisher Scientific in Q2 2015 and has held it in 45 quarters since.
- Bowen Hanes & Co's Thermo Fisher Scientific position peaked at $90.6M in Q4 2021.
- 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on Bowen Hanes & Co's 13F filing for Q2 2026, filed 13 Aug 2026.